208 related articles for article (PubMed ID: 16541250)
1. Free-energy force-field three-dimensional quantitative structure-activity relationship analysis of a set of p38-mitogen activated protein kinase inhibitors.
Romeiro NC; Albuquerque MG; de Alencastro RB; Ravi M; Hopfinger AJ
J Mol Model; 2006 Sep; 12(6):855-68. PubMed ID: 16541250
[TBL] [Abstract][Full Text] [Related]
2. Prediction of ligand-receptor binding thermodynamics by free energy force field three-dimensional quantitative structure-activity relationship analysis: applications to a set of glucose analogue inhibitors of glycogen phosphorylase.
Venkatarangan P; Hopfinger AJ
J Med Chem; 1999 Jun; 42(12):2169-79. PubMed ID: 10377222
[TBL] [Abstract][Full Text] [Related]
3. Construction of 4D-QSAR models for use in the design of novel p38-MAPK inhibitors.
Romeiro NC; Albuquerque MG; de Alencastro RB; Ravi M; Hopfinger AJ
J Comput Aided Mol Des; 2005 Jun; 19(6):385-400. PubMed ID: 16231199
[TBL] [Abstract][Full Text] [Related]
4. Free energy force field (FEFF) 3D-QSAR analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors.
Santos-Filho OA; Mishra RK; Hopfinger AJ
J Comput Aided Mol Des; 2001 Sep; 15(9):787-810. PubMed ID: 11776291
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking.
Ravindra GK; Achaiah G; Sastry GN
Eur J Med Chem; 2008 Apr; 43(4):830-8. PubMed ID: 17706839
[TBL] [Abstract][Full Text] [Related]
6. Prediction of ligand-receptor binding thermodynamics by free energy force field (FEFF) 3D-QSAR analysis: application to a set of peptidometic renin inhibitors.
Tokarski JS; Hopfinger AJ
J Chem Inf Comput Sci; 1997; 37(4):792-811. PubMed ID: 9254912
[TBL] [Abstract][Full Text] [Related]
7. A novel 3D-QSAR comparative molecular field analysis (CoMFA) model of imidazole and quinazolinone functionalized p38 MAP kinase inhibitors.
Sperandio da Silva GM; Sant'Anna CM; Barreiro EJ
Bioorg Med Chem; 2004 Jun; 12(12):3159-66. PubMed ID: 15158784
[TBL] [Abstract][Full Text] [Related]
8. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
[TBL] [Abstract][Full Text] [Related]
9. Insight into the structural determinants of imidazole scaffold-based derivatives as p38 MAP kinase inhibitors by computational explorations.
Huang C; Li Y; Ren H; Wang J; Shao L; Zhang S; Li G; Yang L
Curr Med Chem; 2012; 19(23):4024-37. PubMed ID: 22680637
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling of p38α mitogen-activated protein kinase inhibitors through 3D-QSAR and molecular dynamics simulations.
Chang HW; Chung FS; Yang CN
J Chem Inf Model; 2013 Jul; 53(7):1775-86. PubMed ID: 23808966
[TBL] [Abstract][Full Text] [Related]
11. How good are ensembles in improving QSAR models? The case with eCoRIA.
Khedkar VM; Joseph J; Pissurlenkar R; Saran A; Coutinho EC
J Biomol Struct Dyn; 2015; 33(4):749-69. PubMed ID: 24754910
[TBL] [Abstract][Full Text] [Related]
12. QSAR study of Phenoxypyrimidine Derivatives as Potent Inhibitors of p38 Kinase using different chemometric tools.
Edraki N; Hemmateenejad B; Miri R; Khoshneviszade M
Chem Biol Drug Des; 2007 Dec; 70(6):530-9. PubMed ID: 18034684
[TBL] [Abstract][Full Text] [Related]
13. p38 Mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies.
Gangwal RP; Bhadauriya A; Damre MV; Dhoke GV; Sangamwar AT
Curr Top Med Chem; 2013; 13(9):1015-35. PubMed ID: 23651481
[TBL] [Abstract][Full Text] [Related]
14. Molecular Dynamics Guided Receptor Independent 4D QSAR Studies of Substituted Coumarins as Anticancer Agents.
Patil R; Sawant S
Curr Comput Aided Drug Des; 2015; 11(1):39-50. PubMed ID: 26081557
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling studies to characterize N-phenylpyrimidin-2-amine selectivity for CDK2 and CDK4 through 3D-QSAR and molecular dynamics simulations.
Chohan TA; Chen JJ; Qian HY; Pan YL; Chen JZ
Mol Biosyst; 2016 Apr; 12(4):1250-68. PubMed ID: 26883408
[TBL] [Abstract][Full Text] [Related]
16. Studies of N(9)-arenthenyl purines as novel DFG-in and DFG-out dual Src/Abl inhibitors using 3D-QSAR, docking and molecular dynamics simulations.
Ma S; Zeng G; Fang D; Wang J; Wu W; Xie W; Tan S; Zheng K
Mol Biosyst; 2015 Feb; 11(2):394-406. PubMed ID: 25406390
[TBL] [Abstract][Full Text] [Related]
17. A 3D-QSAR Analysis of CDK2 Inhibitors Using FMO Calculations and PLS Regression.
Yoshida T; Hirono S
Chem Pharm Bull (Tokyo); 2019; 67(6):546-555. PubMed ID: 31155560
[TBL] [Abstract][Full Text] [Related]
18. Insight into the Structural Determinants of Imidazole Scaffold-Based Derivatives as TNF-α Release Inhibitors by in Silico Explorations.
Wang Y; Wu M; Ai C; Wang Y
Int J Mol Sci; 2015 Aug; 16(9):20118-38. PubMed ID: 26307982
[TBL] [Abstract][Full Text] [Related]
19. Modeling the binding affinity of p38α MAP kinase inhibitors by partial least squares regression.
Basant N; Durante C; Cocchi M; Menziani MC
Chem Biol Drug Des; 2012 Sep; 80(3):455-70. PubMed ID: 22642504
[TBL] [Abstract][Full Text] [Related]
20. Structure-based quantitative structure-activity relationship studies of checkpoint kinase 1 inhibitors.
Du J; Xi L; Lei B; Lu J; Li J; Liu H; Yao X
J Comput Chem; 2010 Nov; 31(15):2783-93. PubMed ID: 20839304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]